Endpoints exclusive: Harvard startup raises $26M, strikes three pharma partnerships for AI antibody design
NEW! Test-Time Scaling for De Novo Antibody Design
Read our technical reportNEW! Test-Time Scaling for De Novo Antibody Design
Read our technical report